日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Clinical Outcomes of Pembrolizumab in Head and Neck Squamous Cell Carcinoma Subsites Excluded from the KEYNOTE-048 Trial

帕博利珠单抗治疗未纳入 KEYNOTE-048 试验的头颈部鳞状细胞癌亚部位的临床结果

期刊:Current Oncology
影响因子:3.4
doi:10.3390/curroncol33010057
Yamashita, Gai; Okada, Takuro; Okamoto, Isaku; Kondo, Takahito; Ito, Tatsuya; Fujii, Shota; Kishida, Takuma; Aihara, Yusuke; Hanyu, Kenji; Ueda, Yuri; Tokashiki, Kunihiko; Sato, Hiroki; Harada, Yuki; Momiyama, Kaho; Matsuki, Takashi; Kushihashi, Yukiomi; Masubuchi, Tatsuo; Tada, Yuichiro; Yamashita, Taku; Tsukahara, Kiyoaki
细胞生物学
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Brain metastases in patients with salivary duct carcinoma: A retrospective study

唾液腺导管癌患者脑转移：一项回顾性研究

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.7037
Fushimi, Chihiro; Takahashi, Hideaki; Kawakita, Daisuke; Kano, Satoshi; Tsukahara, Kiyoaki; Ozawa, Hiroyuki; Okami, Kenji; Sakai, Akihiro; Yamazaki, Keisuke; Okada, Takuro; Hanazawa, Toyoyuki; Sato, Yuichiro; Imanishi, Yorihisa; Shimizu, Akira; Matsuki, Takashi; Nagao, Toshitaka; Tada, Yuichiro
肿瘤
肿瘤免疫
神经科学
发表日期：2024
文献求助 收藏

Survival benefit of HER2-targeted or androgen deprivation therapy in salivary duct carcinoma

HER2靶向治疗或雄激素剥夺疗法对唾液导管癌患者的生存获益

期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/17588359221119538
Kawakita, Daisuke; Nagao, Toshitaka; Takahashi, Hideaki; Kano, Satoshi; Honma, Yoshitaka; Hirai, Hideaki; Saigusa, Natsuki; Akazawa, Kohei; Tani, Kaori; Ojiri, Hiroya; Tsukahara, Kiyoaki; Ozawa, Hiroyuki; Okami, Kenji; Kondo, Takahito; Togashi, Takafumi; Fushimi, Chihiro; Shimura, Tomotaka; Shimizu, Akira; Okamoto, Isaku; Okada, Takuro; Imanishi, Yorihisa; Watanabe, Yoshihiro; Otsuka, Kuninori; Sakai, Akihiro; Ebisumoto, Koji; Sato, Yuichiro; Yamazaki, Keisuke; Ueki, Yushi; Hanazawa, Toyoyuki; Saito, Yuki; Ando, Mizuo; Matsuki, Takashi; Nakaguro, Masato; Sato, Yukiko; Urano, Makoto; Utsumi, Yoshitaka; Kohsaka, Shinji; Saotome, Takashi; Tada, Yuichiro
肿瘤
肿瘤免疫
HER2
免疫/内分泌
发表日期：2022
文献求助 收藏

Postoperative Complications and Swallowing Function after Jejunal and Skin Flap Reconstruction for Hypopharyngeal Carcinoma-A Multicenter Retrospective Study

下咽癌空肠皮瓣重建术后并发症及吞咽功能——一项多中心回顾性研究

期刊:Journal of Clinical Medicine
影响因子:2.9
doi:10.3390/jcm11051464
Tokashiki, Kunihiko; Okamoto, Isaku; Okada, Takuro; Sato, Hiroki; Yamashita, Taku; Matsuki, Takashi; Kondo, Takahito; Fushimi, Chihiro; Masubuchi, Tatsuo; Miura, Kouki; Omura, Go; Tsukahara, Kiyoaki
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

The Role of the EZH2 and H3K27me3 Expression as a Predictor of Clinical Outcomes in Salivary Duct Carcinoma Patients: A Large-Series Study With Emphasis on the Relevance to the Combined Androgen Blockade and HER2-Targeted Therapy

EZH2 和 H3K27me3 表达在预测唾液导管癌患者临床结局中的作用：一项大型系列研究，重点关注其与雄激素阻断联合 HER2 靶向治疗的相关性

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2021.779882
Saigusa, Natsuki; Hirai, Hideaki; Tada, Yuichiro; Kawakita, Daisuke; Nakaguro, Masato; Tsukahara, Kiyoaki; Kano, Satoshi; Ozawa, Hiroyuki; Kondo, Takahito; Okami, Kenji; Togashi, Takafumi; Sato, Yukiko; Urano, Makoto; Kajiwara, Manami; Shimura, Tomotaka; Fushimi, Chihiro; Shimizu, Akira; Okamoto, Isaku; Okada, Takuro; Suzuki, Takayoshi; Imanishi, Yorihisa; Watanabe, Yoshihiro; Sakai, Akihiro; Ebisumoto, Koji; Sato, Yuichiro; Honma, Yoshitaka; Yamazaki, Keisuke; Ueki, Yushi; Hanazawa, Toyoyuki; Saito, Yuki; Takahashi, Hideaki; Ando, Mizuo; Kohsaka, Shinji; Matsuki, Takashi; Nagao, Toshitaka
肿瘤
HER2
肿瘤免疫
EZH2
免疫/内分泌
发表日期：2021
文献求助 收藏

Real-World, Long-Term Outcomes of Nivolumab Therapy for Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck and Impact of the Magnitude of Best Overall Response: A Retrospective Multicenter Study of 88 Patients

纳武利尤单抗治疗复发或转移性头颈部鳞状细胞癌的真实世界长期疗效及最佳总体反应程度的影响：一项纳入 88 例患者的回顾性多中心研究

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers12113427
Matsuki, Takashi; Okamoto, Isaku; Fushimi, Chihiro; Takahashi, Hideaki; Okada, Takuro; Kondo, Takahito; Sato, Hiroki; Ito, Tatsuya; Tokashiki, Kunihiko; Tsukahara, Kiyoaki; Hanyu, Kenji; Masubuchi, Tatsuo; Tada, Yuichiro; Miura, Kouki; Omura, Go; Sawabe, Michi; Kawakita, Daisuke; Yamashita, Taku
细胞生物学
肿瘤
肿瘤免疫
发表日期：2020
文献求助 收藏

Hematological predictive markers for recurrent or metastatic squamous cell carcinomas of the head and neck treated with nivolumab: A multicenter study of 88 patients

纳武利尤单抗治疗复发或转移性头颈部鳞状细胞癌的血液学预测标志物：一项纳入88例患者的多中心研究

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.3124
Matsuki, Takashi; Okamoto, Isaku; Fushimi, Chihiro; Sawabe, Michi; Kawakita, Daisuke; Sato, Hiroki; Tsukahara, Kiyoaki; Kondo, Takahito; Okada, Takuro; Tada, Yuichiro; Miura, Kouki; Omura, Go; Yamashita, Taku
细胞生物学
肿瘤
肿瘤免疫
发表日期：2020
文献求助 收藏

Cryptococcal osteomyelitis of the Zygomatic bone: a case report

颧骨隐球菌性骨髓炎：病例报告

期刊:BMC Infectious Diseases
影响因子:3
doi:10.1186/s12879-020-05123-2
Matsuki, Takashi; Miyamoto, Shunsuke; Yamashita, Taku
骨髓炎
发表日期：2020
文献求助 收藏

Investigation of the Efficacy and Safety of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma

纳武利尤单抗治疗复发性和转移性鼻咽癌的疗效和安全性研究

期刊:In Vivo
影响因子:1.8
doi:10.21873/invivo.12127
Sato, Hiroki; Fushimi, Chihiro; Okada, Takuro; Matsuki, Takashi; Kondo, Takahito; Omura, G O; Miura, Kouki; Yamashita, Taku; Okamoto, Isaku; Tsukahara, Kiyoaki
鼻咽癌
肿瘤
肿瘤免疫
发表日期：2020
文献求助 收藏

Carboplatin and Docetaxel in Patients With Salivary Gland Carcinoma: A Retrospective Study

卡铂联合多西他赛治疗唾液腺癌患者：一项回顾性研究

期刊:In Vivo
影响因子:1.8
doi:10.21873/invivo.11549
Okada, Takuro; Saotome, Takashi; Nagao, Toshitaka; Masubuchi, Tatsuo; Fushimi, Chihiro; Matsuki, Takashi; Takahashi, Hideaki; Miura, Kouki; Tsukahara, Kiyoaki; Tada, Yuichiro
肿瘤
肿瘤免疫
发表日期：2019
文献求助 收藏